Next Generation Mid-Capacity Sequencer for 'In-Vitro' Diagnostics [2025] | Tenderlake

Next Generation Mid-Capacity Sequencer for 'In-Vitro' Diagnostics [2025]

Contract Value:
CZK 15M - 15M
Notice Type:
Contract Notice
Published Date:
21 January 2026
Closing Date:
23 February 2026
Location(s):
CZ064 Jihomoravský kraj (CZ Czech Republic/ČESKÁ REPUBLIKA)
Description:
Delivery of a next generation mid-capacity sequencer for in-vitro diagnostics along with related services and consumables as per specified requirements.

The subject of the public procurement is the delivery of a next generation mid-capacity sequencer for in-vitro diagnostics, the provision of related services and the supply of related consumables according to the specifications and terms specified in the relevant Appendix No. 3 of the procurement documentation.


LOT-0001
Next Generation Mid-Capacity Sequencer for 'In-Vitro' Diagnostics [2025].
The subject of the public procurement is the delivery of a next generation mid-capacity sequencer for in-vitro diagnostics, the provision of related services and the supply of related consumables according to the specifications and terms specified in the relevant Appendix No. 3 of the procurement documentation.

The Buyer:
Masarykův onkologický ústav
Additional information:
Link:
View Full Notice
Link:
Download Full Notice as PDF
Link:
Additional document: MOU 517 478
CPV Code(s):
38000000 - Laboratory, optical and precision equipments (excl. glasses)
38434500 - Biochemical analysers